When AI designs a drug, who gets the patent credit?
MIT Technology Review reports that nobody disputes that AI can invent; the open question is recognition under patent law. The article also touches on the US patent office's position.
Who is affected and how
- lawyer
- Patent filings should document the human inventor's contribution.
- corporate lawyer
- Inventor status needs to be clarified when patenting results of AI-assisted research.
Sources
- When AI designs a drug, who gets the credit? | MIT Technology Reviewtechnologyreview.com · Aug 21, 2026
- When AI designs a drug, who gets the credit?businessstory.org · Aug 21, 2026
Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not legal advice.